Literature DB >> 16288013

The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress.

Frank Staib1, Ana I Robles, Lyuba Varticovski, Xin W Wang, Barry R Zeeberg, Michail Sirotin, Victor B Zhurkin, Lorne J Hofseth, S Perwez Hussain, John N Weinstein, Peter R Galle, Curtis C Harris.   

Abstract

Activation of the p53 network plays a central role in the inflammatory stress response associated with ulcerative colitis and may modulate cancer risk in patients afflicted with this chronic disease. Here, we describe the gene expression profiles associated with four microenvironmental components of the inflammatory response (NO*, H2O2, DNA replication arrest, and hypoxia) that result in p53 stabilization and activation. Isogenic HCT116 and HCT116 TP53-/- colon cancer cells were exposed to the NO* donor Sper/NO, H2O2, hypoxia, or hydroxyurea, and their mRNA was analyzed using oligonucleotide microarrays. Overall, 1,396 genes changed in a p53-dependent manner (P < 0.001), with the majority representing a "unique" profile for each condition. Only 14 genes were common to all four conditions. Included were eight known p53 target genes. Hierarchical sample clustering distinguished early (1 and 4 hours) from late responses (8, 12, and 24 hours), and each treatment was differentiated from the others. Overall, NO* and hypoxia stimulated similar transcriptional responses. Gene ontology analysis revealed cell cycle as a key feature of stress responses and confirmed the similarity between NO* and hypoxia. Cell cycle profiles analyzed by flow cytometry showed that NO* and hypoxia induced quiescent S-phase and G2-M arrest. Using a novel bioinformatic algorithm, we identified several putative p53-responsive elements among the genes induced in a p53-dependent manner, including four [KIAA0247, FLJ12484, p53CSV (HSPC132), and CNK (PLK3)] common to all exposures. In summary, the inflammatory stress response is a complex, integrated biological network in which p53 is a key molecular node regulating gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288013      PMCID: PMC1421332          DOI: 10.1158/0008-5472.CAN-05-1714

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 2.  Macrophage responses to hypoxia: relevance to disease mechanisms.

Authors:  J S Lewis; J A Lee; J C Underwood; A L Harris; C E Lewis
Journal:  J Leukoc Biol       Date:  1999-12       Impact factor: 4.962

3.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

4.  IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation.

Authors:  Toby Lawrence; Magali Bebien; George Y Liu; Victor Nizet; Michael Karin
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

5.  Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.

Authors:  S P Hussain; K Raja; P A Amstad; M Sawyer; L J Trudel; G N Wogan; L J Hofseth; P G Shields; T R Billiar; C Trautwein; T Hohler; P R Galle; D H Phillips; R Markin; A J Marrogi; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

6.  Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches.

Authors:  L Wang; Q Wu; P Qiu; A Mirza; M McGuirk; P Kirschmeier; J R Greene; Y Wang; C B Pickett; S Liu
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

7.  Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes.

Authors:  F Jung; L A Palmer; N Zhou; R A Johns
Journal:  Circ Res       Date:  2000-02-18       Impact factor: 17.367

8.  Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.

Authors:  S P Hussain; P Amstad; K Raja; S Ambs; M Nagashima; W P Bennett; P G Shields; A J Ham; J A Swenberg; A J Marrogi; C C Harris
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

9.  High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID).

Authors:  Barry R Zeeberg; Haiying Qin; Sudarshan Narasimhan; Margot Sunshine; Hong Cao; David W Kane; Mark Reimers; Robert M Stephens; David Bryant; Stanley K Burt; Eldad Elnekave; Danielle M Hari; Thomas A Wynn; Charlotte Cunningham-Rundles; Donn M Stewart; David Nelson; John N Weinstein
Journal:  BMC Bioinformatics       Date:  2005-07-05       Impact factor: 3.169

10.  Hydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxide.

Authors:  K Sakano; S Oikawa; K Hasegawa; S Kawanishi
Journal:  Jpn J Cancer Res       Date:  2001-11
View more
  48 in total

1.  Radioprobing the conformation of DNA in a p53-DNA complex.

Authors:  Valeri N Karamychev; Difei Wang; Sharlyn J Mazur; Ettore Appella; Ronald D Neumann; Victor B Zhurkin; Igor G Panyutin
Journal:  Int J Radiat Biol       Date:  2012-06-21       Impact factor: 2.694

Review 2.  Genetics of hepatocellular carcinoma.

Authors:  Andreas Teufel; Frank Staib; Stephan Kanzler; Arndt Weinmann; Henning Schulze-Bergkamen; Peter-R Galle
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

3.  Carrageenan induces cell cycle arrest in human intestinal epithelial cells in vitro.

Authors:  Sumit Bhattacharyya; Alip Borthakur; Pradeep K Dudeja; Joanne K Tobacman
Journal:  J Nutr       Date:  2008-03       Impact factor: 4.798

4.  DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected].

Authors:  Federica Polato; Paolo Rusconi; Stefano Zangrossi; Federica Morelli; Mattia Boeri; Alberto Musi; Sergio Marchini; Vittoria Castiglioni; Eugenio Scanziani; Valter Torri; Massimo Broggini
Journal:  J Natl Cancer Inst       Date:  2014-03-20       Impact factor: 13.506

5.  p53 suppresses CCL2-induced subcutaneous tumor xenograft.

Authors:  Xiaoren Tang; Salomon Amar
Journal:  Tumour Biol       Date:  2014-12-11

Review 6.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 7.  A cytokine-mediated link between innate immunity, inflammation, and cancer.

Authors:  Wan-Wan Lin; Michael Karin
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

Authors:  Kensuke Kumamoto; Elisa A Spillare; Kaori Fujita; Izumi Horikawa; Taro Yamashita; Ettore Appella; Makoto Nagashima; Seiichi Takenoshita; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

9.  Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia.

Authors:  Chun-Seok Cho; Gregory J Kato; Seung Ha Yang; Sung Won Bae; Jong Seo Lee; Mark T Gladwin; Sue Goo Rhee
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

10.  Regulation of redox signaling by selenoproteins.

Authors:  Wayne Chris Hawkes; Zeynep Alkan
Journal:  Biol Trace Elem Res       Date:  2010-03-20       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.